Summary
A representative sample (n=2140) of the Israeli Jewish population aged 40–70 (excluding known diabetic patients), whose body mass index had been measured 10 years earlier, underwent an oral glucose tolerance test and redetermination of body mass index. Irrespective of weight changes, high concurrent and high past body mass index values (≥ 27) were associated with similarly increased rates of glucose intolerance as compared with body mass index values < 27 at both time-points (rate ratio 1.76, 90% confidence limits 1.56–1.99). Glucose intolerance here includes borderline and impaired tolerance as well as Type 2 diabetes. The rate of Type 2 diabetes increased only with increasing past body mass index, while concurrent body mass index had no effect [rate ratios: 2.36 (1.48–3.75) and 1.99 (1.48–2.68) respectively for the medium-(23–26.9) versus-low (<23) and high- (≥ 27) versus-medium past body-mass-index categories]. Weight reduction was associated with only slightly reduced rate of glucose intolerance and had no effect on the rate of diabetes. Mean sum insulin (summed 1 and 2 h levels, mU/l) increased significantly with increasing concurrent body mass index (123, 150 and 190 in the low, medium and high categories) with no effect of past body mass index. It also increased significantly (p < 0.001) in all concurrent body mass index categories from normal tolerance through borderline to impaired tolerance, and decreased significantly (p < 0.001) in diabetes relative to impaired tolerance, although it remained above normal. Means of sum insulin within each glucose tolerance level were similar in the two lower concurrent body mass index categories, with markedly higher (p < 0.001) levels in the high body mass index category. All these findings held after accounting for age, sex, ethnic group and use of antihypertensive medications. We conclude that body mass index ≥ 27 leads to early impairment in glucose tolerance. A prolonged period of obesity is apparently required for the development of Type 2 diabetes and its associated reduced insulin response. The reversibility of the deterioration of glucose tolerance seems to be limited.
Article PDF
Similar content being viewed by others
References
Joslin EP (1921) The prevention of diabetes mellitus. JAMA 76:79–84.
John HF (1929) A summary of findings in 1100 glucose tolerance estimations. Endocrinology 13:388–392
West KM (1978) Epidemiology of diabetes and its vascular lesions. Elsevier - North Holland, New York
WHO Expert Committee on Diabetes Mellitus (1980) Technical Report Series No. 646. Geneva: World Health Organization
Zimmet P (1982) Type 2 (non-insulin-dependent) diabetes - an epidemiologic overview. Diabetologia 22:399–411
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057
Himsworth HP (1936) Diabetes mellitus: Its differentiation into insulin sensitive and insulin insensitive types. Lancet 1:117–120
Yalow RS, Berson SA (1960) Plasma insulin concentrations in non-diabetics and early diabetic subjects. Determinations by a new sensitive immunoassay technique Diabetes 9:254–260
Rabinowitz D, Zierler KL (1962) Forearm metabolism in obesity and its response to intra-arterial insulin: Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest 41:2173–2181
Karam JH, Grodsky GM, Forsham PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12:197–204
Abrams ME, Jarrett RJ, Keen H, Boyns DR, Crossley JH (1969) Early glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol and other factors with glucose and insulin response. Br Med J 1: 599–602
Olefsky JM, Kolterman OJ, Scarlett JA (1982) Insulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. Am J Physiol 243:E 15–30
DeFronzo RA, Ferrannini E (1982) The pathogenesis of non-insulin-dependent diabetes: An update. Medicine 61:125–140
Reaven GM (1980) Insulin independent diabetes mellitus. Metabolic characteristics. Metabolism 29:445–454
Halverson JD, Kramer J, Cave A, Permutt A, Santiago J (1982) Altered glucose tolerance, insulin response and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery 92:235–240
Grunberger G, Taylor SI, Dons RF, Gorden P (1983) Insulin receptors in normal and disease states. Clin Endocrinol Metabol 12:191–219
Westlund K, Nicolaysen R (1972) Ten-year mortality and morbidity related to serum cholesterol. Scan J Clin Lab Invest 30 [Suppl 127]:1–24
Knowler WC, Pettitt DJ, Savage PJ, Bennett PH (1981) Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113:144–156
Medalie JH, Papier CM, Goldbourt U, Herman JB (1975) Major factors in the development of diabetes mellitus in 10000 men. Arch Intern Med 135:811–817
Butler WJ, Ostrander LD Jr., Carmen WJ, Lamphiear DE (1982) Diabetes mellitus in Tecumseh, Michigan. Previance, incidence and associated conditions. Am J Epidemiol 116:971–980
21. Murphy MB, Kohner E, Lewis PJ, Schumer B, Dollery CT (1982) Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 2:1293–1295
Flamenbaum W (1983) Metabolic consequences of antihypertensive therapy. Annals of Intern Med 98:875–880
Modan M, Halkin H, Karasik A, Lusky A (1984) Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. The Israel Study of Glucose Intolerance, Obesity and Hypertension. Am J Epidemiol 119:431–444
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia — a link between hypertension obesity and glucose intolerance. J Clin Invest 75:809–817
Cerasi E, Efendic S, Luft R (1973) Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1:794–797
Miettinen OS (1976) Estimability and estimation in case referent studies. Am J Epidemiol 103:226–235
Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73–78
King H, Zimmet P, Raper LR, Balkau B (1984) The natural history of impaired glucose tolerance in the Micronesian population of Nauru: A six-year follow-up study. Diabetologia 26:39–43
Sasaki A, Suzuki T, Horiuchi N (1982) Development of diabetes in Japanese subjects with impaired glucose tolerance: A seven-year follow-up study. Diabetologia 22:154–157
Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44–49
Noppa H (1980) Body weight change in relation to incidence of ischemic heart disease and change in risk factors for ischemic heart disease. Am J Epidemiol 111:693–704
Ashley FW Jr., Kannel WB (1974) Relation of weight change to changes in atherogenic traits: the Framingham study. J Chron Dis 27:103–114
Chiang BN, Perlman LV, Epstein FH (1969) Overweight and hypertension. A review. Circulation 39:403–421
Sims EAH (1982) Mechanisms of hypertension in the overweight. Hypertension 4 (Suppl III):III-43–III-49
Cohen AM (1961) Prevalence of diabetes among different ethnic Jewish groups in Israel. Metabolism 10:50–58
Keys A (1980) W.O. Atwater Memorial Lecture: Overweight, obesity, coronary heart disease and mortality. Nutr Rev 38:297–307
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Modan, M., Karasik, A., Halkin, H. et al. Effect of past and concurrent body mass index on prevalence of glucose intolerance and Type 2 (non-insulin-dependent) diabetes and on insulin response. Diabetologia 29, 82–89 (1986). https://doi.org/10.1007/BF00456115
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00456115